Promising Practice Series: 30-minute Talks with Dr. Lisa Letourneau and Maine leaders Maine Leaders Andrea Truncali, MD, MPH Christine Wyman, LCSW, LADC, CCS
Promising Practice Series: 30-minute Talks with Dr. Lisa Letourneau and Maine leaders Maine Leaders Christine Munroe, DO Director at the Recovery Center Eric Haram, LADC, Haram Consulting LLC.
This session will review the initiation of buprenorphine for OUD using the microdosing and macrodosing approaches. We will review why these emerging approaches are preferable to traditional approaches, the supporting evidence, and the practical pearls for implementation. Learning Objectives: Describe microdosing and macrodosing approaches to buprenorphine initiation Recall the evidence supporting each of these approaches
Through this interactive workshop participants will learn more about stigma, its impact on healthcare delivery, patients, and the community. To accomplish this, the workshop will include methods that will enable the participants to explore their beliefs regarding stigma, and develop the knowledge, skills, attitudes, and intellectual strategies that are essential to addressing stigma in their
The presenter will explore the promising and best practices on the use of XR Buprenorphine and naltrexone. The ways the medications can be delivered and practical issues of certification in the SUBLOCADE REMS program, storage, and administration will be discussed. Learning objectives: Assess which patients are appropriate for treatment with the extended release (XR) formulation